CRpEF: Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction

Sponsor
Henry Ford Health System (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02762825
Collaborator
(none)
66
1
2
79
0.8

Study Details

Study Description

Brief Summary

Patients with HFpEF suffer from exercise intolerance, increased risk for hospitalization and mortality, and poor QOL. Unlike patients with HFrEF, no drug or device therapies appear to be consistently beneficial in treating these problems. However, increasing evidence suggests that exercise training is effective for both partially reversing exercise intolerance and improving quality of life in these patients. Most such trials to date have been conducted in controlled research setting, versus integrating these patients in to a standard CR program. Also, since functional capacity is related to outcomes in these patients, exercise strategies aimed at further improving fitness are warranted. One such strategy is using higher intensity interval training (HIIT) in the CR setting, a strategy shown to be effective in patients with other types of CVD. This project is designed to test the feasibility of incorporating these patients into the CR setting, and training them using a methodology (i.e., HIIT) already shown to yield (in other patients with CVD) greater gains in fitness when compared to what was achieved using standard MCT alone.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: HIIT
  • Behavioral: MCT
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction
Actual Study Start Date :
Mar 1, 2016
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Higher Intensity Interval Training (HIIT)

Behavioral: HIIT
HIIT will consist of 4 min of higher intensity work set at 90% of heart rate reserve, based on peak heart rate from CPX test. Recovery intervals will be 3-4 min in duration and set at 60-70% of heart rate reserve. Resistance training will be performed once per week.

Active Comparator: Moderate Continuous Training (MCT)

Behavioral: MCT
MCT will consist of aerobic exercise performed 3 times per week for 30 min each session, at an intensity of 60-80% of heart rate reserve, based on peak heart rate from CPX test.

Outcome Measures

Primary Outcome Measures

  1. Change in peak oxygen consumption from baseline [Change from baseline at 10-12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. NYHA class II or III symptoms

  2. Referred by physician to CR with echocardiographic evidence of HFpEF defined as an ejection fraction ≥ 50 % and moderate to severe (grade II-III) diastolic dysfunction.

  3. ≥ 50 years of age

  4. Free of orthopedic or other medical problems that would limit participation in CR

  5. Peak VO2 on baseline cardiopulmonary exercise test (CPX) < 24 mL/kg/min in men and <21 mL/kg/min in women

Exclusion Criteria:
  1. Systolic dysfunction, per ejection fraction < 50%; those with mild (grade I) diastolic dysfunction

  2. Initial clinical responses observed during first 3 visits in CR or baseline exercise test that would preclude participation in study over-all (e.g., new onset/troublesome arrhythmia that warrants further investigation) or undergoing HIIT (e.g., claudication, balance issue)

  3. Patients with exercise induced angina during CR or CPX testing or ST segment depression representative of myocardial ischemia during CPX testing

  4. Pregnant or planning to become pregnant

  5. Any patient recently hospitalized for heart failure will have to wait at least 2 weeks before starting CR, or until clinically stable per physician(whichever time period is greater)

  6. Atrial fibrillation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Henry Ford Hospital Detroit Michigan United States 48202

Sponsors and Collaborators

  • Henry Ford Health System

Investigators

  • Principal Investigator: Steven Keteyian, PhD, Henry Ford Health System

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Steven J. Keteyian, Principal Investigator, Henry Ford Health System
ClinicalTrials.gov Identifier:
NCT02762825
Other Study ID Numbers:
  • HFHS HFpEF HIIT
First Posted:
May 5, 2016
Last Update Posted:
Aug 8, 2022
Last Verified:
Aug 1, 2022
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2022